We appreciate the interest shown by Tomaselli et al regarding our study on left atrial strain measures as predictors of subclinical atrial fibrillation (AF) in the LOOP study (Atrial Fibrillation Detected by Continuous Electrocardiogram Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-risk Individuals). 1 Tomaselli et al highlight that it would be worthwhile to consider the right atrium (RA), including RA strain, as a potential marker of AF risk. We agree with Tomaselli et al that RA size and function have been neglected in the context of AF, particularly considering that AF would be expected to involve both atria. This is supported by the presence of biatrial fibrosis observed in AF. 2 It is indeed possible that RA strain may be more valuable than RA size, similar to what has been observed for the left atrium. 1 RA reservoir strain seems a reliable indicator of elevated RA pressure 3 and, contrary to RA size, has been shown to be significantly associated with RA fibrosis. 2 Additionally, international societies have proposed practical guidelines for benchmarking RA strain assessment. 4 It is, therefore, encouraging that Tomaselli et al have embarked on evaluating RA strain as a predictor of AF recurrence, 5 albeit their findings should be interpreted in the context of the small sample size and retrospective design of their study. The prospective design of the LOOP study with long-term continuous rhythm monitoring, end point adjudication, and echocardiographic analyses blinded to outcomes provides a unique framework to extend the findings by Tomaselli et al. We are currently in the process of meticulously analyzing RA size and function and look forward to sharing our findings on how these relate to subclinical AF. In the long term, studies are still needed to translate risk markers into clinical benefit for the patients. Hopefully, our findings will foster studies that explore how such potential markers of atrial cardiomyopathy may be used to guide clinical management.